30 Nov Introduction of new feature “Biosimilar medicines” in the Medicinal Product Register of Latvia
In order to facilitate the availability of information regarding the potential biological origin of medicines to healthcare professionals, as well as to allow other users of the Medicinal Product Register of Latvia to better orient themselves among the medicinal products included in the register, as well as to facilitate compliance with the
regulation regarding the procedure for writing out prescriptions, the State Agency of Medicines introduces a new feature “biosimilar medicines” that will be visible beside the name of the active substance.
From now on the “biosimilar medicines” criteria will also be available as a search parameter in the advanced search form of the Medicinal Product Register of Latvia.
For more information, please contact local consultant in Estonia